Our CEO, Nigel Theobald, has written an article for Drug Discovery Today about the emerging vaccine delivery systems for COVID-19. He talks about how functionalised silica nanoparticles, like Nuvec®, offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines, and may be useful in the race to develop a COVID-19 vaccine. Read the full paper for a limited time here: https://bit.ly/3drxjrd
